ClinicalTrials.gov
public full text
Public Domain
Randomised Placebo-controlled Duloxetine-referenced Efficacy and Safety Study of 2.5, 5 and 10 mg of Vortioxetine (Lu AA21004) in Acute Treatment of Major Depressive Disorder
The purpose of the study is to evaluate the efficacy and the tolerability of three fixed doses of Vortioxetine in order to establish the appropriate clinical effective dose range in the treatment of Major Depressive Disorder (MDD).
Conceptio Open Archive
Analyze & explore related research in Conceptio
Connect this record directly into your research workflow or AI agent. Explore citations across open repositories, query full text, and export structured proof bundles.
This document is indexed with metadata only: full text is not available in the archive for this record. Open the official source ↗
Related documents
- Study With Vortioxetine on Emotional Functioning in Patients With Depression#852210
- Real-life Effectiveness of Vortioxetine in Depression#1045332
- A Phase 3 Study of Lu AA21004 in Patients With Major Depressive Disorder#810998
- Efficacy of Vortioxetine (Lu AA21004) in the Prevention of Relapse of Major Depressive Episodes#874481
- Duloxetine for Chronic Depression: a Double-blind Study#1161603
Record · ID 1100442
Retrieved via Conceptio: every document is proof-bundled with source, license, and retrieval metadata.
Retrieved via Conceptio: every document is proof-bundled with source, license, and retrieval metadata.
Bring this data into your agent: Connect via MCP or API · 20 free credits to start · no card required
Read the Docs → · View CLI source on GitHub · Conceptio Open Knowledge Archive
Read the Docs → · View CLI source on GitHub · Conceptio Open Knowledge Archive